Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | GAA | P10253 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 0.46 |
| ▸ | GUCY1B1 | Q02153 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9363410 | 0.84 | RAPGEF4 (0.52) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| SCHEMBL7536862 | 0.83 | GUCY1A1 (0.51) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| SCHEMBL8348988 | 0.82 | RAPGEF4 (0.52) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| Hydrochloric Acid SCHEMBL21248268 | 0.81 | GUCY1A1 (0.50) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| SCHEMBL1485822 | 0.80 | RECQL (0.62) | CYP3A4TSHRRECQLHTTALDH1A1 | |
| SCHEMBL13204732 | 0.80 | HTT (0.53) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| SCHEMBL24131528 | 0.78 | TSHR (0.41) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| SCHEMBL21812018 | 0.78 | TSHR (0.60) | CYP3A4TSHRRECQLHTTALDH1A1 | |
| SCHEMBL1645546 | 0.78 | TSHR (0.60) | CYP3A4TSHRRECQLHTTRAPGEF4 | |
| SCHEMBL20707057 | 0.78 | CYP1A2 (0.42) | CYP3A4TSHRRECQLHTTRAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230136150-A1 | Compositions for Inhibition of Insect Sensing | UNIV VANDERBILT (US) | 2023-05-04 | — | — | US | disclosed |
| US-20210219551-A1 | Compositions for Inhibition of Insect Sensing | VANDERBILT UNIVERSITY | 2021-07-22 | — | — | US | disclosed |
| US-10813355-B2 | Compositions for inhibition of insect sensing | VANDERBILT UNIVERSITY (US) | 2020-10-27 | — | — | US | disclosed |
| US-20190075798-A1 | Compositions for Inhibition of Insect Sensing | VANDERBILT UNIVERSITY | 2019-03-14 | — | — | US | disclosed |
| EP-3345907-A1 | NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-20160045528-A1 | COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS | ALIOS BIOPHARMA, INC. | 2016-02-18 | — | — | US | disclosed |
| US-20160045528-A1 | COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS | ALIOS BIOPHARMA, INC. | 2016-02-18 | — | — | US | disclosed |
| WO-2016022464-A1 | COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS | ALIOS BIOPHARMA, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| CN-102975508-B | Reversible thermosensitive recording medium | RICOH CO LTD | 2014-12-03 | — | — | CN | disclosed |
| US-8883837-B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | JANSSEN PHARMACEUTICA NV (BE) | 2014-11-11 | — | — | US | disclosed |
| US-20040005607-A1 | Non-fluorescent quencher compounds and biomolecular assays | APPLIED BIOSYSTEMS, LLC | 2004-01-08 | — | — | US | disclosed |
| US-20030082547-A1 | Non-fluorescent quencher compounds and biomolecular assays | APPLIED BIOSYSTEMS, LLC | 2003-05-01 | — | — | US | disclosed |
| WO-2003019145-A2 | NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS | APPLERA CORPORATION (US) | 2003-03-06 | — | — | WO | disclosed |
| CN-1057552-C | Triphenodioxazine dyes and preparation and application of same | ZENECA LTD (GB) | 2000-10-18 | — | — | CN | disclosed |
| EP-0576123-B1 | Watersoluble triphenodioxazine dye | AVECIA LTD (GB) | 2000-03-01 | — | — | EP | disclosed |
| EP-0428482-B1 | Reactive dyes, process for their preparation and their use | CIBA GEIGY AG (CH) | 1995-05-31 | — | — | EP | disclosed |
| EP-0576123-A1 | Watersoluble triphenodioxazine dye | ZENECA LIMITED (GB) | 1993-12-29 | — | — | EP | disclosed |
| US-5136028-A | Red; colorfastness | CIBA-GEIGY CORPORATION (US) | 1992-08-04 | — | — | US | disclosed |
| EP-0428482-A1 | Reactive dyes, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1991-05-22 | — | — | EP | disclosed |
| US-3992405-A | ESPECIALLY FOR DYEING POLYACRYLIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230136150-A1 | Compositions for Inhibition of Insect Sensing | OR51E2, TRPA1, OR10J3 | CYP3A4 3922/4885TSHR 2971/4885RECQL 4067/4885 |
| US-10813355-B2 | Compositions for inhibition of insect sensing | OR51E2, TRPA1, OR10J3 | CYP3A4 3964/4885TSHR 3088/4885RECQL 3986/4885 |
| US-20030082547-A1 | Non-fluorescent quencher compounds and biomolecular assays | DNTT, PNP, NT5C2 | CYP3A4 864/4885TSHR 1442/4885RECQL 376/4885 |
| US-20160045528-A1 | COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS | MAVS, EIF2AK2, SARS1 | CYP3A4 4543/4885TSHR 3851/4885RECQL 1171/4885 |
| US-20210219551-A1 | Compositions for Inhibition of Insect Sensing | OR51E2, TRPA1, OR10J3 | CYP3A4 3922/4885TSHR 2971/4885RECQL 4067/4885 |
| US-20040005607-A1 | Non-fluorescent quencher compounds and biomolecular assays | DNTT, PNP, NT5C2 | CYP3A4 864/4885TSHR 1442/4885RECQL 376/4885 |
| US-20190075798-A1 | Compositions for Inhibition of Insect Sensing | OR51E2, TRPA1, OR10J3 | CYP3A4 3964/4885TSHR 3088/4885RECQL 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.